24 January 2024
To respond to the changing regulatory environment and enhance equitable access to quality assured health products, the Global Fund has updated its Quality Assurance Policy for Pharmaceuticals [ download in English | Español | Français ] and Quality Assurance Policy for Medical Devices (including In Vitro Diagnostics) and Core Personal Protective Equipment [ download in English | Español | Français ] . The latter, replacing the original Quality Assurance Policy for Diagnostics, has been expanded to include additional medical devices such as core personal protective equipment (PPE) and condoms.
Countries can refer to this document [ download in English ] for guidance on the updates to the two policies and their implications. These amendments, approved by the Global Fund Board on 15 November 2023: